| Title： | EPG Evidence-Based Clinical Practice Guideline for Diagnosis and Treatment of Type 2 Diabetes in Children and Adolescents |
| Edition： | Adapted |
| Classification： | Standard guideline |
| Field： | Diagnosis and Treatment |
| Countries and regions： | Egypt |
| Guidelines users： | Pediatric Endocrinologists and Diabetologists, Clinical Pharmacists, & Nurses |
| Evidence classification method： | The 'Formal' Guideline Adaptation Process (Wang et al 2018) followed by the EPG is the 'Adapted ADAPTE' (Amer et al 2015) that includes three phases (set up, adaptation, and finalization). Critical appraisal or quality assessment or evaluation of the eligible source original guidelines is conducted by using the AGREE II Instrument. The rating system for the hierarchy of evidence will follow the same system of the original guideline(s) with their permission. |
| Development unit： | Egyptian Pediatric Clinical Practice Guidelines Committee (EPG) |
| Registration time: | 2023-04-25 |
| Registration number： | PREPARE-2023CN271 |
| Purpose of the guideline: | To identify evidence-based recommendations for the following interventions:- • Diagnosis of Type 2 DM: – History and clinical examination. – Laboratory diagnosis. – Diagnosis of comorbidities and complications. • Treatment of Type 2 DM – Dietetic intervention. – Lifestyle modification. – Pharmacological treatment. – Indications and role of bariatric surgery. – Treatment of comorbidities. – Treatment of complications. |
Latest registration
